A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
© 2018 The Author(s) Background: Reducing the dose of efavirenz can improve safety, reduce costs, and increase access for patients with HIV infection. According to the World Health Organization, a similar dosing strategy for all patient populations is desirable for universal roll-out; however, it re...
Saved in:
Main Authors: | Stein Schalkwijk, Rob Ter Heine, Angela C. Colbers, Alwin D.R. Huitema, Paolo Denti, Kelly E. Dooley, Edmund Capparelli, Brookie M. Best, Tim R. Cressey, Rick Greupink, Frans G.M. Russel, Mark Mirochnick, David M. Burger |
---|---|
格式: | 雜誌 |
出版: |
2018
|
主題: | |
在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85043397210&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/58961 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
由: Stein Schalkwijk, et al.
出版: (2018) -
Efavirenz pharmacokinetics during pregnancy and infant washout
由: Regis Kreitchmann, et al.
出版: (2019) -
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling
由: Stein Schalkwijk, et al.
出版: (2019) -
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
由: Tim R. Cressey, et al.
出版: (2018) -
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
由: Cressey T., et al.
出版: (2017)